GET DAILY SIGNALSGXPS vs IYK: Contrasting Approaches to U.S. Consumer Staples Exposure
Key Takeaways
- Both GXPS and IYK are passively managed U.S. consumer staples exchange-traded funds (ETFs), but they pursue structurally different weighting and selection rules.
- GXPS uses an uncapped, free-float market-capitalization methodology with no single-name caps, while IYK tracks a capped benchmark (22.5%/45% limits) that also blends in healthcare and materials names.
- GXPS is materially cheaper, with a net expense ratio of about 0.15% versus roughly 0.37% for IYK.
- GXPS is more concentrated and heavily anchored in WMT and COST, whereas IYK is broader, holds more names, and excludes those large-cap retailers.
- IYK is larger, more liquid, and offers a higher dividend yield, while GXPS is a younger, smaller fund launched in 2025.
- Tickeron AI Verdict: GXPS is favored based on cost efficiency, purer mega-cap sector exposure, and a simpler, transparent weighting structure.
Why These Two Consumer Staples ETFs Warrant a Closer Look
Consumer staples often serve as a defensive component in equity portfolios, so comparing two ETFs that target the same broad sector makes sense for investors evaluating their options. GXPS and IYK both provide exposure to U.S. companies involved in everyday essentials, yet they are not interchangeable. GXPS offers a straightforward, uncapped market-capitalization perspective on the sector, while IYK applies weighting limits and includes modest allocations outside pure staples. I also checked this using Tickeron’s AI Screener to see how the funds align with broader industry peers. Recognizing these differences allows investors to match a fund’s characteristics more closely with their own portfolio goals.
A Closer Look at GXPS and Its PureCap Structure
GXPS aims to follow the MSCI USA Consumer Staples Index and delivers what Global X describes as "PureCap" exposure through uncapped, free-float market-capitalization weighting without any company-level restrictions. The absence of caps leads to a heavier tilt toward the sector’s largest companies. The fund relies on representative sampling and typically holds 30 to 33 securities, with around 80% of assets in the top 10 holdings. Its main positions generally feature WMT (Walmart), COST (Costco), PG (Procter & Gamble), KO (Coca-Cola), PM (Philip Morris International), PEP (PepsiCo), MO (Altria), and MDLZ (Mondelez). Exposure spans Food, Beverage & Tobacco, Consumer Staples Distribution & Retail, and Household & Personal Products. The fund is non-diversified, carries a net expense ratio of approximately 0.15% (gross 0.25%), and was launched in July 2025, so it remains newer and smaller in assets under management than many longer-established options.
Understanding IYK and Its Capped Benchmark
IYK tracks the Russell 1000 Consumer Staples RIC 22.5/45 Capped Index, which includes U.S. consumer staples equities subject to caps that limit the largest holdings (22.5% for any single name and 45% for a 5% issuer group). This capping sets it apart from pure market-cap strategies. The fund has been in operation since June 2000 and typically holds 53 to 57 securities, providing wider diversification. Top holdings usually include PG, KO, PM, PEP, MO, CVS (CVS Health), MCK (McKesson), MDLZ, CL (Colgate-Palmolive), and MNST (Monster Beverage). Notably, IYK does not hold Walmart or Costco and instead maintains a meaningful healthcare allocation (roughly 13% to 14%, led by CVS and McKesson) along with a small materials component, so it is not a pure staples vehicle. It carries a management fee of about 0.37% to 0.38% and tends to deliver a higher dividend yield.
The Broader Consumer Staples Environment
Both funds operate in the consumer defensive space, where performance is influenced by consumer spending patterns, input costs, pricing dynamics, and interest-rate expectations. Defensive sectors have attracted more attention lately as investors balance slower growth with persistent inflation pressures. Staples firms have used pricing power and cost controls to support margins, while retailers and distributors have adjusted to changing consumer behavior. Regulatory and public-health factors also affect certain areas such as tobacco, and a higher-for-longer rate environment generally supports sectors with steady cash flows and dividends. Key risks involve margin compression, weaker volumes, and—for IYK specifically—healthcare distribution and pharmacy-related challenges.
Performance Positioning and Key Trade-Offs
In recent periods, both funds have generally tracked the wider consumer staples group, though their structural differences influence outcomes. GXPS’s uncapped design concentrates exposure in mega-caps such as Walmart and Costco, which can magnify both upside and downside moves during sector shifts. IYK’s capping and healthcare tilt have historically resulted in lower beta, reflecting a more diversified and defensive stance. Fees remain an important long-term consideration: GXPS’s roughly 0.15% net expense ratio is less than half of IYK’s, creating a structural edge that compounds over time. On the other side, IYK provides greater liquidity, a longer history, and a higher income yield that may suit income-focused investors. Relative results have therefore hinged more on each fund’s specific weighting rules, diversification level, and fee impact than on the sector itself. From what I see, these distinctions matter when aligning choices with individual risk preferences.
Exploring AI-Powered Research Tools
I regularly turn to Tickeron’s AI Screener when comparing ETFs like these, as it lets me apply technical patterns, fundamentals, and AI signals to scan across sectors efficiently. The tool helps surface relevant ideas and benchmark positioning without manual effort, which has proven useful for refining sector allocations. It’s become a practical part of my routine for evaluating options such as consumer staples funds.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
IYK's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for IYK turned positive on October 07, 2026. Looking at past instances where IYK's MACD turned positive, the stock continued to rise in 38 of 44 cases over the following month. The odds of a continued upward trend are 86%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on IYK as a result. In 70 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.
IYK moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for IYK crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 72%.
Following a +2.27% 3-day Advance, the price is estimated to grow further. Considering data from situations where IYK advanced for three days, in 265 of 336 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
The Aroon Indicator entered an Uptrend today. In 232 of 299 cases where IYK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 78%.
Bearish Trend Analysis
The 10-day RSI Indicator for IYK moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In 30 of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at 79%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 43 of 61 cases where IYK's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 70%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IYK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
IYK broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Category ConsumerStaples
Advertisement